Antithrombotic drugs market

Published on Jul 4, 2014in Nature Reviews Drug Discovery57.62
· DOI :10.1038/nrd4365
Kritika Chaudhari4
Estimated H-index: 4
Bashar Hamad5
Estimated H-index: 5
Basharut A. Syed10
Estimated H-index: 10
Thrombotic events are a major complication of cardiovascular disease. Despite the availability of a large range of antithrombotic therapies, demand persists for safe, effective new drugs and antidotes that allow control of their activity. This article investigates the antithrombotic drug pipeline and the changing landscape of the antithrombotics market.
  • References (0)
  • Citations (24)
Cited By24
#1Shanshan Huang (Shanghai Institute of Technology)
#2Yujie Ren (Shanghai Institute of Technology)
Last.Lingwei Meng (Shanghai Institute of Technology)
view all 5 authors...
#1Douglas Siqueira de Almeida Chaves (UFRRJ: Universidade Federal Rural do Rio de Janeiro)H-Index: 2
#2Giany O. De MeloH-Index: 6
view all 3 authors...
#1Zahra Memariani (Babol University of Medical Sciences)H-Index: 6
#2Reihaneh Moeini (Babol University of Medical Sciences)H-Index: 3
Last.Seyyed Ali Mozaffarpur (Babol University of Medical Sciences)H-Index: 3
view all 5 authors...
#1Zhe Xu (MOE: Chinese Ministry of Education)H-Index: 1
#2Ruonan Liu (MOE: Chinese Ministry of Education)H-Index: 1
Last.Huashi Guan (MOE: Chinese Ministry of Education)H-Index: 1
view all 3 authors...
#1Janaki Krishnamoorthy Iyer (McMaster University)H-Index: 1
#2Cho Yeow Koh (NUS: National University of Singapore)H-Index: 12
Last.R. Manjunatha Kini (NUS: National University of Singapore)H-Index: 50
view all 11 authors...
View next paperNovel antithrombotic therapy.